Neurotrophin-3 contributes to benefits of human embryonic stem cell-derived cardiovascular progenitor cells against reperfused myocardial infarction

Overview of attention for article published in Stem Cells Translational Medicine, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

twitter: 3 X users

facebook: 2 Facebook pages

Readers on

mendeley: 16 Mendeley

So far, Altmetric has seen 11 public wall posts from 2 users.

Stem Cells Translational Medicine, 20 May 2021

While implantation of human embryonic stem cell‐derived cardiovascular progenitor cells (hCVPCs) can promote the recovery of…

Stem Cells Portal, 19 Apr 2021

NT‐3 Treatment as a Novel Cell-free Therapeutic Approach for Myocardial Infarction-associated Injury (https://bit.ly/2Q61Nrz) …

Stem Cells Translational Medicine, 19 Apr 2021

NT‐3 Treatment as a Novel Cell-free Therapeutic Approach for Myocardial Infarction-associated Injury (https://bit.ly/2Q61Nrz) …

Stem Cells Portal, 17 Apr 2021

STEM CELLS Translational Medicine - May 2021 - Volume 10, Issue 5 (https://bit.ly/3gc3qOL) PLURIPOTENT STEM CELLS …

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 7 additional Facebook posts.